Logo for Cessatech

Cessatech Investor Relations Material

Latest events

Logo for Cessatech

Q1 2024

15 May, 2024
Logo for Cessatech

Q4 2023

29 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Cessatech

Access all reports
Cessatech A/S is a biopharmaceutical company dedicated to identifying, developing and commercializing drugs for children with the potential to treat cancer and fibrotic disorders. The company's focus of research and development is based on the proteins in regulatory T-cells (Tregs) that suppress an immune system response to secondary disease processes, such as cancer and fibrosis.